Itamar Medical Ltd. (ITMR): Price and Financial Metrics
GET POWR RATINGS... FREE!
ITMR POWR Grades
- ITMR scores best on the Sentiment dimension, with a Sentiment rank ahead of 91.12% of US stocks.
- The strongest trend for ITMR is in Sentiment, which has been heading up over the past 31 weeks.
- ITMR ranks lowest in Quality; there it ranks in the 5th percentile.
ITMR Stock Summary
- ITMR's went public 2.28 years ago, making it older than only 5.12% of listed US stocks we're tracking.
- Over the past twelve months, ITMR has reported earnings growth of 2,760.54%, putting it ahead of 99.28% of US stocks in our set.
- Revenue growth over the past 12 months for Itamar Medical Ltd comes in at 98.22%, a number that bests 93.98% of the US stocks we're tracking.
- Stocks with similar financial metrics, market capitalization, and price volatility to Itamar Medical Ltd are ITRN, ERF, ORI, GRVY, and MX.
- Visit ITMR's SEC page to see the company's official filings. To visit the company's web site, go to www.itamar-medical.com.
ITMR Stock Price Chart Interactive Chart >
ITMR Price/Volume Stats
|Current price||$21.60||52-week high||$29.00|
|Prev. close||$21.44||52-week low||$17.18|
|Day high||$21.60||Avg. volume||42,366|
|50-day MA||$22.04||Dividend yield||N/A|
|200-day MA||$21.96||Market Cap||347.93M|
Itamar Medical Ltd. (ITMR) Company Bio
Itamar Medical Ltd. engages in the research, development, marketing, sale, and leasing of non-invasive medical devices for the cardiology market. The company offers medical devices based on Peripheral Arterial Tone (PAT) signal, which measures changes in the patient's peripheral arterial pulse volumes and various parameters of arterial activities. It provides WatchPAT device, which enables home sleep tests for various sleeping disorders, including obstructive sleep apnea; and Endo PAT device that diagnoses endothelial dysfunction. The company operates in the United States, Canada, Europe, Israel, Japan, the Asia Pacific, and other countries. Itamar Medical Ltd. has a collaboration agreement with SoClean Inc. to offer WatchPAT ONE home sleep apnea test and digital health services through direct-to-consumer channels. The company was formerly known as Itamar Medical (CM) 1997 Ltd. and changed its name to Itamar Medical Ltd. in July 2000. Itamar Medical Ltd. was founded in 1997 and is headquartered in Caesarea, Israel.
ITMR Latest News Stream
|Loading, please wait...|
ITMR Latest Social Stream
View Full ITMR Social Stream
Latest ITMR News From Around the Web
Below are the latest news stories about Itamar Medical Ltd that investors may wish to consider to help them evaluate ITMR as an investment opportunity.
Enables Patient Smartphone App to Collect Subjective Data at Time of Test Designed to Improve the Quality and Efficiency of Home Sleep Diagnostics CAESAREA, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced two enhancements to its WatchPAT™ product line that the Company plans to unveil on June 11 durin
Itamar Medical Ltd. (ITMR) Q1 2021 Earnings Conference Call May 19, 2021, 08:00 AM ET Company Participants Leigh Salvo - IR Gilad Glick - CEO Shy Basson - CFO Conference Call Participants Matthew O'Brien - Piper Sandler Josh Jennings - Cowen Richard Newitter - SVB Leerink Jeffrey Cohen - Ladenburg...
Itamar Medical (ITMR): Q1 Non-GAAP EPADS of -$0.20 beats by $0.01; GAAP EPADS of -$0.36 misses by $0.15.Revenue of $12M (+43.2% Y/Y) beats by $0.88M.Press Release...
Itamar Medical to Report First Quarter Financial Results and Host Conference Call on Wednesday, May 19, 2021
CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results for the first quarter 2021 before the U.S. market opens on Wednesday, May 19, 2021. The Company will host a conference call that day at 8:00 a.m. Eastern Time, 3:00 p.m. Israel Time to review financial results and provide a corporate update. The call will be hosted by Gilad Glick, President and CEO, and Shy Basson, CFO. To listen live via webcast, please visit https://edge.media-server.com/mmc/p/vemth6m6. To participate via phone, please use the following dial in information:U.S. toll-free: 1-8...
Significant Majority Expect Home Sleep Apnea Test Usage to Expand and in-lab Usage to Decline Most Clinicians Expect More than Half of Future Sleep Diagnostics Will Be At-Home Tests Results Indicate Vast Majority of Participants Use HSAT in Their Practices Today CAESAREA, Israel, April 12, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced results from a recent survey to health care professionals that covered sleep testing dynamics in their practices during 2020 and expectations for future use of Home Sleep Apnea Testing (HSAT) versus Polysomnography (PSG) testing performed in sleep laboratories. Key findings o...
ITMR Price Returns